New Zealand vs Singapore: Diabetes treatment coverage, crude
New Zealand
57.78
in 2022
Singapore
57.31
in 2022
New Zealand rank
47th
Singapore rank
50th
Diabetes treatment coverage, crude over time
- New Zealand
- Singapore
How they compare
New Zealand currently reports 57.78 against 57.31 in Singapore, a difference of 0.47.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Singapore ahead.
New Zealand ranks 47th and Singapore ranks 50th of 198 countries.
Singapore has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | New Zealand | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 39.45 | 50.63 | 11.18 | Singapore |
| 2000s | 45.71 | 54 | 8.29 | Singapore |
| 2010s | 53 | 56.35 | 3.36 | Singapore |
| 2020s | 57.22 | 57.25 | 0.0378 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diabetes treatment coverage, crude, New Zealand or Singapore?
- New Zealand, at 57.78 against 57.31 in Singapore as of 2022.
- What is the difference in diabetes treatment coverage, crude between New Zealand and Singapore?
- 0.47, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Singapore?
- 33 years are reported by both, from 1990 to 2022.
- How do New Zealand and Singapore rank globally for diabetes treatment coverage, crude?
- New Zealand ranks 47th and Singapore ranks 50th of 198 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diabetes treatment coverage, crude. Statizoid refreshes it automatically from the source and publishes the full history for both places.